Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 39 citing articles:

The role of PI3k/AKT signaling pathway in attenuating liver fibrosis: a comprehensive review
Emad Shamsan, Maged Almezgagi, Mohammed Gamah, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 22
A comprehensive review of vine tea: Origin, research on Materia Medica, phytochemistry and pharmacology
Tiexin Zeng, Yanjun Song, Shunyao Qi, et al.
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116788-116788
Closed Access | Times Cited: 32
Nrf2/HO‐1, NF‐κB and PI3K/Akt signalling pathways decipher the therapeutic mechanism of pitavastatin in early phase liver fibrosis in rats
Marawan A. Elbaset, Bassim M. S. A. Mohamed, Alyaa F. Hessin, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 3
Open Access | Times Cited: 11
A dihydromyricetin-loaded phellinus igniarius polysaccharide/l-arginine modified chitosan-based hydrogel for promoting wound recovery in diabetic mice via JNK and TGF-β/Smad signaling pathway
Jiali Yang, Lifeng Zhang, Shuwen Sun, et al.
International Journal of Biological Macromolecules (2024) Vol. 259, pp. 129124-129124
Closed Access | Times Cited: 9
Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt/β-catenin signaling pathway in mice
Quanwen Liu, Yan-Min Ying, Jiaxin Zhou, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 38
Plant‐derived flavonoids are a potential source of drugs for the treatment of liver fibrosis
Bolin Zhao, Kai Liu, Xing Liu, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 3122-3145
Closed Access | Times Cited: 8
Dihydromyricetin alleviates methotrexate-induced hepatotoxicity via suppressing the ‎TLR4/NF-κB pathway and NLRP3 inflammasome/caspase 1 axis
Asmaa I. Matouk, Eman M. Awad, Nashwa Fathy Gamal El‐Tahawy, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113752-113752
Open Access | Times Cited: 23
Isovitexin alleviates hepatic fibrosis by regulating miR-21-mediated PI3K/Akt signaling and glutathione metabolic pathway: based on transcriptomics and metabolomics
Yushen Huang, Wen Luo, Siyun Chen, et al.
Phytomedicine (2023) Vol. 121, pp. 155117-155117
Closed Access | Times Cited: 13
STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations
Osama A. Mohammed, Mustafa Ahmed Abdel‐Reheim, Mohannad Mohammad S. Alamri, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1080-1080
Open Access | Times Cited: 12
Dihydromyricetin Modulates Nrf2 and NF-κB Crosstalk to Alleviate Methotrexate-Induced Lung Toxicity
Asmaa I. Matouk, Eman M. Awad, Nashwa Fathy Gamal El‐Tahawy, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 481-481
Open Access | Times Cited: 11
Revealing immune infiltrate characteristics and potential immune-related genes in hepatic fibrosis: based on bioinformatics, transcriptomics and q-PCR experiments
Yan-Ming Bai, Shuang Liang, Bo Zhou
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
SIRT1/Nrf2/NF-κB Signaling Mediates Anti-Inflammatory and Anti-Apoptotic Activities of Oleanolic Acid in a Mouse Model of Acute Hepatorenal Damage
Manea A. I. Alqrad, Dina S. El‐Agamy, Sabrin R. M. Ibrahim, et al.
Medicina (2023) Vol. 59, Iss. 7, pp. 1351-1351
Open Access | Times Cited: 11
Effects of dietary dihydromyricetin on growth performance, antioxidant capacity, immune response and intestinal microbiota of shrimp (Litopenaeus vannamei)
Mingxiang Lu, R Liu, Zhifei Chen, et al.
Fish & Shellfish Immunology (2023) Vol. 142, pp. 109086-109086
Closed Access | Times Cited: 10
Dihydromyricetin: an emerging compound with comprehensive effects on multiple systems
Chengyi He, Yunfei Chen, Jiao Xie, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Protective effects and metabolomics analysis of dihydromyricetin on cyclophosphamide-induced hepatotoxicity in mice
Fei Teng, Haina Wang
Pharmaceutical Science Advances (2025), pp. 100063-100063
Open Access
Ruminococcus bromii-generated acetate alleviated Clonorchis sinensis-induced liver fibrosis in mice
Chun Li, Changsheng Cheng, Liping Jiang, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Suppression of TP Rat Pancreatic Acinar Cell Apoptosis by hucMSC‐Ex Carrying hsa‐miR‐21‐5p via PTEN/PI3K Regulation
Zhirong Zhao, Kexin Jiang, Mu Yuan, et al.
Stem Cells International (2025) Vol. 2025, Iss. 1
Open Access
Mechanisms of Dihydromyricetin for Improving Hepatic Fibrosis through the Integration of Metabolomics and Gut Microbiota
Ying Gao, Hao Wu, Yanqun Luo, et al.
The American Journal of Chinese Medicine (2025) Vol. 53, Iss. 03, pp. 889-908
Closed Access
Gomisin D alleviates liver fibrosis through targeting PDGFRβ in hepatic stellate cells
Rong Wang, Fangbin Liu, Panpan Chen, et al.
International Journal of Biological Macromolecules (2023) Vol. 235, pp. 123639-123639
Open Access | Times Cited: 9
Dihydromyricetin Inhibits M1 Macrophage Polarization in Atherosclerosis by Modulating miR-9-Mediated SIRT1/NF-κB Signaling Pathway
Zhousheng Yang, Tianyu Li, Chunyan Wang, et al.
Mediators of Inflammation (2023) Vol. 2023, pp. 1-11
Open Access | Times Cited: 9
The potential of flavonoids in hepatic fibrosis: A comprehensive review
Wenbo Zhu, Jianwei Han, Liu Hua, et al.
Phytomedicine (2024) Vol. 133, pp. 155932-155932
Closed Access | Times Cited: 3
Dihydromyricetin protects against gentamicin-induced nephrotoxicity via upregulation of renal SIRT3 and PAX2
Asmaa I. Matouk, Eman M. Awad, Amr A.K. Mousa, et al.
Life Sciences (2023) Vol. 336, pp. 122318-122318
Closed Access | Times Cited: 7
Probing Liver Injuries Induced by Thioacetamide in Human In Vitro Pooled Hepatocyte Experiments
Himanshu Goel, Richard L. Printz, Venkat R. Pannala, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3265-3265
Open Access | Times Cited: 2
Chitosan-modified dihydromyricetin liposomes promote the repair of liver injury in mice suffering from diabetes mellitus
Qiteng Ding, Xinglong Liu, Shuai Zhang, et al.
International Journal of Biological Macromolecules (2024) Vol. 273, pp. 133040-133040
Closed Access | Times Cited: 2
The protective effects of aqueous extract of Schisandra sphenanthera against alcoholic liver disease partly through the PI3K-AKT-IKK signaling pathway
Ding Liu, Kai Yang, Taotao Li, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e34214-e34214
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top